IgA nephropathy: an overview of drug treatments in clinical trials

H Selvaskandan, G Gonzalez-Martin… - Expert Opinion on …, 2022 - Taylor & Francis
ABSTRACT Introduction IgA nephropathy (IgAN) is the commonest primary
glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within …
被引用次数：20 相关文章

IgA nephropathy: an overview of drug treatments in clinical trials

H Selvaskandan, G Gonzalez-Martin… - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction IgA nephropathy (IgAN) is the commonest primary glomerulonephritis
worldwide and may progress to end-stage kidney disease (ESKD) within a 10-20 year …

IgA nephropathy: an overview of drug treatments in clinical trials.

H Selvaskandan, G Gonzalez-Martin… - Expert Opinion on …, 2023 - europepmc.org
IgA nephropathy (IgAN) is the commonest primary glomerulonephritis worldwide and may
progress to end-stage kidney disease (ESKD) within a 10-20 year period. Its slowly …